Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interest of Low-dose Landiolol Administration After Cardiac Surgery for the Prevention of Postoperative Atrial Fibrillation

NCT04607122 is registered in ClinicalTrials.gov with CMC Ambroise Paré as lead sponsor.

NCT NCT04607122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04607122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interest of Low-dose Landiolol Administration After Cardiac Surgery for the Prevention of Postoperative Atrial Fibrillation
Lead sponsor
CMC Ambroise Paré
Phase
Phase 3
Overall status
Completed
Start date
January 27, 2021
Completion date
July 22, 2023
Enrollment
400 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, cardiac surgery